Flavoxate |
Urispas |
Article: Flavoxate
![]() | |
| Flavoxate | |
| Systematic (IUPAC) name | |
| 2-(1-piperidyl)ethyl 3-methyl-4-oxo-2-phenyl-chromene-8-carboxylate | |
| Identifiers | |
| CAS number | 15301-69-6 |
| ATC code | G04BD02 |
| PubChem | 3354 |
| DrugBank | APRD00972 |
| Chemical data | |
| Formula | C24H25NO4 |
| Mol. weight | 391.46 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | ? |
Flavoxate is an anticholinergic with antimuscarinic effects. Its muscle relaxant properties may be due to a direct action on the smooth muscle rather than by antagonizing muscarinic receptors.
Clinical uses
Flavoxate is used to treat urinary bladder spasms. It is available under the trade name Urispas (Paladin).

Not Signed In - 


